EXAGEN INC. - COMMON STOCK

Exagen Inc. to Participate in Upcoming Investor Conferences

04 Feb 2025 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results

12 Jan 2025 12:00:00 By Nasdaq GlobeNewswire

Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD

12 Dec 2024 09:00:00 By Nasdaq GlobeNewswire

Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform

14 Nov 2024 16:30:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in Fourth Quarter Investor Conferences

13 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports Third Quarter 2024 Results

12 Nov 2024 08:00:01 By Nasdaq GlobeNewswire

Exagen to Announce Third Quarter 2024 Results on November 12, 2024

29 Oct 2024 16:05:00 By Nasdaq GlobeNewswire

Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence

21 Oct 2024 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference

04 Sep 2024 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance

05 Aug 2024 08:00:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference

02 Aug 2024 09:00:00 By Nasdaq GlobeNewswire

Exagen Appoints Jeffrey G. Black as New Chief Financial Officer

01 Aug 2024 09:00:00 By Nasdaq GlobeNewswire

Exagen to Announce Second Quarter 2024 Results on August 5, 2024

22 Jul 2024 09:00:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year

13 May 2024 08:00:00 By Nasdaq GlobeNewswire

Exagen Announces Campaign for Lupus Awareness Month

06 May 2024 16:05:00 By Nasdaq GlobeNewswire

Exagen to Announce First Quarter 2024 Results on May 13, 2024

30 Apr 2024 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Announces Changes to the Board of Directors

26 Apr 2024 08:30:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results

18 Mar 2024 08:00:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

08 Mar 2024 09:00:00 By Nasdaq GlobeNewswire

Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024

07 Mar 2024 16:05:00 By Nasdaq GlobeNewswire